SC-DARIC33 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SC-DARIC33 CAR T cells, covering 2025-12-23 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML [Phase 1]